Relay Therapeutics
This leadership role oversees the late-stage development and manufacturing of small molecule drug candidates at global CRO/CMO sites, ensuring regulatory compliance and driving processes toward commercialization. The position requires managing technical transfers, troubleshooting scale-up issues, and collaborating with cross-functional teams to support project advancement. Key responsibilities include reviewing critical documents, writing regulatory submissions, and implementing optimized manufacturing processes.
Headquarters
Cambridge, Massachusetts, United States
Company Size
51-200 employees
Founded
2016
Relay Therapeutics is a biotechnology company that puts protein motion at the heart of drug discovery, using computational modeling, machine learning, and experimental structural biology to reveal dynamic protein states and identify novel therapeutic opportunities. The company applies this platform to design and advance small‑molecule drug candidates, translating dynamic insights into lead programs and partnerships. Relay’s approach aims to expand the set of druggable targets and accelerate development of medicines across multiple disease areas.
Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Consensus Rating of "Moderate Buy" from Analysts
18 hours ago
Relay Therapeutics (RLAY) Soars 5.4%: Is Further Upside Left in the Stock?
1 day ago
Insider Sell: Thomas Catinazzo Sells Shares of Relay Therapeutics Inc (RLAY)
23 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Relay Therapeutics.
Zovegalisib Milestones To Shape The Future Of Relay Therapeutics
1 day ago
Associate Director, Drug Substance (Process Chemistry)
Pulmovant
Senior Research Director, Analytical Chemistry - Synthetic Molecule Design and Development
Eli Lilly and Company
Director, Process Chemistry
Treeline Biosciences
Senior Director, CMC Drug Substance Development & Manufacturing
Olema Oncology
Drug Substance Manufacturing Manager
Exelixis
Senior Director, Drug Substance (Small Molecule)
Structure Therapeutics